A ladder that shows its working
Monthly, three-month and six-month, for each drug, with the billed amount stated beside the per-month figure and a savings percentage beside that. The monthly tier is described as billed monthly with no commitment, which makes it the only genuinely monthly figure of the three.
The six-month tiers are single billings and are stored here as such. A promotional strip advertises a lifetime lock at the six-month rate, which is the lowest figure on the page and the one that requires the largest commitment.
One floor for two drugs
Its category card lists both drugs together under a single as-low-as figure. That figure is the semaglutide six-month rate. The tirzepatide floor is substantially higher, and it is on the page a click away.
A reader arriving at the card and stopping there would be badly wrong about one of the two products. Both figures are recorded here.
A host that never says no
The nonsense path we ran against this host returned a status of 200 with ten thousand characters of plausible page. That means an address alone proves nothing here: any check that treats a successful response as evidence a page exists will be fooled.
The two treatment pages were separated from that behaviour by resolving to their own addresses and returning distinct bodies with distinct prices. That is the second, independent signal that makes them real rather than an artefact. Its operating company is named on its about page; no compounding pharmacy, clinician or service area is published.
Yucca Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $146/mothe monthly plan, "Billed monthly · no commitment"; the seller prints its own "Save 40.7%" beside it | September 2026source |
| Semaglutide (compounded) | $125$750 billed every 6 months, not a monthly charge; the three-month tier is $420 billed every 3 months, quoted as $140/mo | September 2026source |
| Tirzepatide (compounded) | $258/mothe monthly plan, billed monthly with no commitment | September 2026source |
| Tirzepatide (compounded) | $225$1,350 billed every 6 months; the three-month tier is $744 billed every 3 months, quoted as $248/mo | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See Yucca Health's current price →Good fit if
- Readers comparing a no-commitment monthly rate against a six-month prepayment from one seller.
- Buyers who want the amount actually billed printed beside every per-month figure.
- People who want a stated promise that the price does not move with the dose.
Look elsewhere if
- Anyone taking the category card's single figure as the price of tirzepatide.
- Readers who want a monthly rate at the advertised lowest figure, which is a six-month prepayment.
- Buyers who need a named pharmacy, a named clinician or a service-area list.
- Anyone checking this site themselves who might read a successful response as proof a page exists.
How this review was verified
- Ran a nonsense path against the host in the same run as every fetch and recorded that it returned a 200 with a full page body, then treated no address on this host as self-proving.
- Re-read both treatment pages and the about page on 7 September 2026, confirming each resolved to its own effective address and returned a distinct body with distinct prices — the independent signal that separates them from the control.
- Recorded all three tiers for both drugs and stored the six-month tiers as non-monthly with the single billed amount in the qualifier.
- Recorded the category card's single floor separately from the two drug ladders rather than treating it as either drug's price.
- Screened the brand against FDA's live warning-letter datatable with a positive control and a nonsense negative control in the same invocation; the screen returned zero matches.